LCN2 and kidney injury: From a practical perspective, urine biomarkers—notably NGAL, KIM-1, MCP-1, and DKK3—offer non-invasive, rapid, and repeatable testing; among them, urinary NGAL and KIM-1 are currently the closest to routine clinical adoption for early detection and ongoing monitoring of kidney injury.